A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia
Clinical trial NCT02988973 · COMPLETED
Trial details
- NCT number
- NCT02988973
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-12
- Primary completion
- 2019-09-13
- Enrollment
- 334
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.